Is C-peptide a predictor of severity of coronary artery disease in metabolic syndrome? An observational study

C肽能否预测代谢综合征患者冠状动脉疾病的严重程度?一项观察性研究

阅读:1

Abstract

BACKGROUND: Various cardiovascular disease (CVD) risk factors have been implicated to correlate with the severity of the disease. Present study was conducted to correlate one such risk factor i.e. fasting serum C-peptide with the presence or absence and the severity of CVD in Indian population. METHODS: 68 patients with metabolic syndrome who underwent coronary angiogram for suspected CVD were included. Their fasting serum C-peptide levels were measured in addition to routine biochemical and cardiological tests. They were divided into 2 groups - those with a positive coronary angiography findings (Group 1) and those with normal coronary angiograms (Group 2). The former group was further divided into those with an Acute Coronary Syndrome (ACS) (Group 1a) and those with Chronic Stable Angina (CSA) (Group 1b). SYNTAX scoring was done to assess the severity of coronary artery disease in groups 1a and 1b. Levels of C-peptide were compared between the groups. RESULTS: The mean C-peptide of all patients was 1.9 (±0.8) ng/mL. Among the group 2 patients, mean serum C-peptide value was 1.6 (±0.4) ng/mL. And it was 2.7 (±0.8) ng/mL and 1.7 (±0.9) ng/mL among the ACS and the CSA groups respectively. The ACS and CSA group had statistically significant higher values of C-peptide compared to patients with normal coronary angiograms. The two-way ANOVA done to find out the variability of C-peptide among the 3 groups revealed significant differences among the groups with a p-value of <0.001. When correlated with SYNTAX scores, this yielded significant results. CONCLUSION: C-peptide levels appear to correlate with the severity of the CVD as measured by SYNTAX score.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。